A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) — Stella
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(115 sites)
United States
Alabama Neurology Associates- Site Number : 8400019, Homewood, Alabama
Honor Health Scottsdale Osborn Medical Center- Site Number : 8400014, Scottsdale, Arizona
Keck School of Medicine of University of Southern California- Site Number : 8400002, Los Angeles, California
University of California Irvine Medical Center- Site Number : 8400007, Orange, California
Yale University School of Medicine- Site Number : 8400018, New Haven, Connecticut
AdventHealth Orlando- Site Number : 8400006, Orlando, Florida
AdventHealth Site Number : 8400006, Orlando, Florida
NorthShore University Health System - Glenbrook Hospital- Site Number : 8400024, Glenview, Illinois
University of Kansas Medical Center- Site Number : 8400010, Kansas City, Kansas
Ochsner Medical Center - Jefferson Highway- Site Number : 8400030, New Orleans, Louisiana
Johns Hopkins Hospital- Site Number : 8400015, Baltimore, Maryland
Massachusetts General Hospital- Site Number : 8400009, Boston, Massachusetts
Argentina
Investigational Site Number : 0320001, Buenos Aires
Investigational Site Number : 0320002, Buenos Aires
Investigational Site Number : 0320003, Buenos Aires
Belgium
Investigational Site Number : 0560002, Ghent
Investigational Site Number : 0560001, Leuven
Brazil
L2IP - Instituto de Pesquisas Clínicas- Site Number : 0760006, Brasília, Federal District
Instituto de Neurologia de Curitiba - Ecoville- Site Number : 0760007, Curitiba, Paraná
InsCer - Instituto do Cérebro da PUCRS- Site Number : 0760002, Porto Alegre, Rio Grande do Sul
PSEG Centro de Pesquisa Clínica- Site Number : 0760009, São Paulo
Canada
Investigational Site Number : 1240003, London, Ontario
Investigational Site Number : 1240006, Montreal, Quebec
Investigational Site Number : 1240001, Québec, Quebec
China
Investigational Site Number : 1560013, Beijing
Investigational Site Number : 1560010, Beijing
Investigational Site Number : 1560005, Beijing
Investigational Site Number : 1560017, Beijing
Investigational Site Number : 1560009, Changsha
Investigational Site Number : 1560011, Chengdu
Investigational Site Number : 1560002, Fuzhou
Investigational Site Number : 1560012, Guangzhou
Investigational Site Number : 1560007, Guangzhou
Investigational Site Number : 1560014, Hangzhou
Investigational Site Number : 1560016, Jiazhuang
Investigational Site Number : 1560008, Jinan
Investigational Site Number : 1560015, Nanchang
Czechia
Investigational Site Number : 2030004, Brno
Investigational Site Number : 2030003, Hradec Králové
Investigational Site Number : 2030005, Ostrava
Investigational Site Number : 2030002, Pardubice
Investigational Site Number : 2030001, Prague
Denmark
Investigational Site Number : 2080002, Aarhus
Investigational Site Number : 2080001, Copenhagen
France
Investigational Site Number : 2500001, Le Kremlin-Bicêtre
Investigational Site Number : 2500002, Marseille
Investigational Site Number : 2500005, Nice
Investigational Site Number : 2500003, Paris
Germany
Investigational Site Number : 2760003, Berlin
Investigational Site Number : 2760008, Bochum
Investigational Site Number : 2760006, Göttingen
Investigational Site Number : 2760005, Hanover
Investigational Site Number : 2760001, Münster
Hungary
Investigational Site Number : 3480003, Budapest
Investigational Site Number : 3480004, Győr
Investigational Site Number : 3480001, Szeged
Israel
Investigational Site Number : 3760001, Haifa
Italy
Investigational Site Number : 3800001, Padua, Padova
Investigational Site Number : 3800002, Bologna
Japan
Investigational Site Number : 3920007, Amagasaki, Hyōgo
Investigational Site Number : 3920015, Yokohama, Kanagawa
Investigational Site Number : 3920012, Higashi-Matsuyama, Saitama
Investigational Site Number : 3920005, Kawagoe, Saitama
Investigational Site Number : 3920014, Yaizu, Shizuoka
Investigational Site Number : 3920008, Kodaira, Tokyo
Investigational Site Number : 3920010, Ōta-ku, Tokyo
Investigational Site Number : 3920001, Chiba
Investigational Site Number : 3920009, Saga
Mexico
Investigational Site Number : 4840002, Chihuahua City
Investigational Site Number : 4840001, Tlalnepantla
Norway
Investigational Site Number : 5780001, Oslo
Portugal
Investigational Site Number : 6200003, Braga
Investigational Site Number : 6200005, Coimbra
Investigational Site Number : 6200002, Lisbon
Investigational Site Number : 6200001, Lisbon
Spain
Investigational Site Number : 7240012, Santiago de Compostela, A Coruña [La Coruña]
Investigational Site Number : 7240009, Barcelona, Barcelona [Barcelona]
Investigational Site Number : 7240006, Sabadell, Barcelona [Barcelona]
Investigational Site Number : 7240001, Barcelona, Catalunya [Cataluña]
Investigational Site Number : 7240008, Majadahonda, Madrid
Investigational Site Number : 7240002, Pamplona, Navarre
Investigational Site Number : 7240003, Oviedo, Principality of Asturias
Investigational Site Number : 7240007, Málaga
Investigational Site Number : 7240010, Santa Cruz de Tenerife
Investigational Site Number : 7240004, Valencia
Sweden
Investigational Site Number : 7520001, Stockholm
Switzerland
Investigational Site Number : 7560001, Basel
Investigational Site Number : 7560003, Bern
Taiwan
Investigational Site Number : 1580003, Kaohsiung City
Investigational Site Number : 1580001, Taipei
Investigational Site Number : 1580002, Taipei
Turkey (Türkiye)
Investigational Site Number : 7920004, Bursa
Investigational Site Number : 7920001, Istanbul
Investigational Site Number : 7920002, Istanbul
Investigational Site Number : 7920003, Konya
United Kingdom
Investigational Site Number : 8260007, London, England
Investigational Site Number : 8260003, Inverness, Highland
Investigational Site Number : 8260001, Oxford, Oxfordshire
Henry Ford Hospital- Site Number : 8400025, Detroit, Michigan
Michigan State University- Site Number : 8400038, East Lansing, Michigan
Washington University School of Medicine - Siteman Cancer Center- Site Number : 8400037, St Louis, Missouri
Dent Neurologic Institute - Amherst- Site Number : 8400039, Amherst, New York
Hospital for Special Surgery- Site Number : 8400041, New York, New York
Columbia University Irving Medical Center- Site Number : 8400003, New York, New York
Raleigh Neurology Associates- Site Number : 8400043, Raleigh, North Carolina
University of Cincinnati Medical Center- Site Number : 8400020, Cincinnati, Ohio
University Hospitals Cleveland Medical Center- Site Number : 8400033, Cleveland, Ohio
Penn Medicine: University of Pennsylvania Health System- Site Number : 8400022, Philadelphia, Pennsylvania
Austin Neuromuscular Center- Site Number : 8400040, Austin, Texas
University of Vermont Medical Center- Site Number : 8400012, Burlington, Vermont
University of Virginia- Site Number : 8400023, Charlottesville, Virginia